Published May 25, 2017 | Version v1
Patent Open

CHIMERIC ANTIGEN RECEPTORS RECOGNIZING CANCER-SPECIFIC TN GLYCOPEPTIDE VARIANTS

Contributors

Patent applicant:

Description

Disclosed are binding proteins, or fragments thereof, that specifically binds to a cancer-specific glycosylation variant of a protein and to a second epitope on the same protein, to a different protein presented on the same cell, or to a different protein presented on a different cell, such as an encoded polypeptide binding to both a cancer cell and an activated T cell. Also disclosed are polynucleotides encoding such binding proteins, including polynucleotides comprising codon-optimized coding regions and polynucleotides comprising coding regions that are not codon-optimized for expression in a particular host cell. Also disclosed are methods of making the encoded polypeptide and methods of using the polypeptide to treat, prevent or ameliorate the symptom of a disease such as cancer.

Files

US20170145108.pdf

Files (2.9 MB)

Name Size Download all
md5:ac3d3a3485af459f2cfcb5313ec52686
2.9 MB Preview Download

Additional details

Identifiers

Patent application number
US 201515117063 A
Patent number
US 2017/0145108 A1
Other
oai:uchicago.tind.io:9122

Dates

Patent filed
2015-02-05

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Cancer Biology, Pathology